Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

How much do you know about eyes? Learn more about the fastest muscle in the human body.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.